Koninklijke Philips Operating Income 2012-2025 | PHG

Koninklijke Philips annual/quarterly operating income history and growth rate from 2012 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Koninklijke Philips operating income for the quarter ending September 30, 2025 was $0.385B, a 56.24% decline year-over-year.
  • Koninklijke Philips operating income for the twelve months ending September 30, 2025 was $1.375B, a 171.29% increase year-over-year.
  • Koninklijke Philips annual operating income for 2025 was $1.611B, a 181.45% increase from 2024.
  • Koninklijke Philips annual operating income for 2024 was $0.572B, a 559.92% decline from 2023.
  • Koninklijke Philips annual operating income for 2023 was $-0.124B, a 92.27% decline from 2022.
Koninklijke Philips Annual Operating Income
(Millions of US $)
2025 $1,611
2024 $572
2023 $-124
2022 $-1,610
2021 $654
2020 $1,761
2019 $1,842
2018 $2,029
2017 $1,715
2016 $2,083
2015 $1,102
2014 $646
2013 $2,645
2012 $1,325
2011 $1,443
Koninklijke Philips Quarterly Operating Income
(Millions of US $)
2025-09-30 $385
2025-06-30 $455
2025-03-31 $163
2024-09-30 $372
2024-06-30 $879
2023-06-30 $242
2023-03-31 $-626
2022-06-30 $12
2021-06-30 $102
2020-06-30 $252
2019-06-30 $392
2018-06-30 $355
2017-06-30 $278
2016-12-31 $902
2016-09-30 $537
2016-06-30 $425
2016-03-31 $220
2015-12-31 $178
2015-09-30 $381
2015-06-30 $386
2015-03-31 $157
2014-12-31 $2
2014-09-30 $-121
2014-06-30 $455
2014-03-31 $310
2013-12-31 $962
2013-09-30 $615
2013-06-30 $665
2013-03-31 $403
2012-12-31 $95
2012-09-30 $745
2012-06-30 $206
2012-03-31 $586
2011-12-31 $-38
2011-09-30 $200
2011-06-30 $334
2011-03-31 $831
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $30.091B $20.173B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $195.936B 21.88
EssilorLuxottica (ESLOY) France $142.091B 0.00
Stryker (SYK) United States $140.083B 26.86
Medtronic (MDT) Ireland $127.548B 17.67
Boston Scientific (BSX) United States $110.783B 24.50
Medline (MDLN) United States $58.526B 0.00
Lonza Group Ag (LZAGY) Switzerland $48.093B 0.00
ResMed (RMD) United States $36.791B 24.57
GE HealthCare Technologies (GEHC) United States $36.615B 17.54
Agilent Technologies (A) United States $35.584B 22.55
Terumo (TRUMY) Japan $21.610B 25.26
Zimmer Biomet Holdings (ZBH) United States $19.115B 11.76
Insulet (PODD) United States $17.076B 53.00
Smith & Nephew SNATS (SNN) United Kingdom $15.372B 0.00
Baxter (BAX) United States $10.182B 8.72
Sunny Optical Technology (SNPTF) China $8.485B 0.00
Bio-Rad Laboratories (BIO) United States $6.921B 25.86
Demant (WILYY) Denmark $6.042B 0.00
Envista Holdings (NVST) United States $4.747B 24.14
Lantheus Holdings (LNTH) United States $4.601B 14.02
BillionToOne (BLLN) United States $4.056B 0.00
ICU Medical (ICUI) United States $3.577B 22.71
Shandong Weigao Medical Polymer (SHWGF) China $3.263B 0.00
Prestige Consumer Healthcare (PBH) United States $3.160B 14.91
Haemonetics (HAE) United States $2.684B 11.74
Neogen (NEOG) United States $2.380B 52.10
Phibro Animal Health (PAHC) United States $2.118B 18.66
Perrigo (PRGO) Ireland $2.001B 5.01
LeMaitre Vascular (LMAT) United States $1.989B 40.03
Curaleaf Holdings (CURLF) Canada $1.642B 0.00
AtriCure (ATRC) United States $1.623B 0.00
QuidelOrtho (QDEL) United States $1.602B 11.12
Kestra Medical Technologies (KMTS) United States $1.571B 0.00
Green Thumb Industries (GTBIF) United States $1.446B 63.36
AdaptHealth (AHCO) United States $1.381B 20.00
Lumexa Imaging Holdings (LMRI) United States $1.358B 0.00
BioLife Solutions (BLFS) United States $1.070B 317.57
Capricor Therapeutics (CAPR) United States $1.026B 0.00
InMode (INMD) Israel $0.906B 9.93
Tilray Brands (TLRY) Canada $0.875B 0.00
Valneva SE (VALN) France $0.868B 0.00
Omeros (OMER) United States $0.829B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.757B 0.00
CeriBell (CBLL) United States $0.733B 0.00
VAREX IMAGING (VREX) United States $0.566B 13.52
Brainsway (BWAY) Israel $0.451B 76.63
Canopy Growth (CGC) Canada $0.436B 0.00
Cerus (CERS) United States $0.430B 0.00
Verano Holdings (VRNO) United States $0.396B 0.00
SNDL (SNDL) Canada $0.386B 0.00
Cresco Labs (CRLBF) United States $0.361B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.328B 0.00
Viemed Healthcare (VMD) United States $0.315B 25.09
Evolus (EOLS) United States $0.279B 0.00
Quanterix (QTRX) United States $0.268B 0.00
TriSalus Life Sciences (TLSI) United States $0.243B 0.00
Owens & Minor (OMI) United States $0.217B 2.17
Sanuwave Health (SNWV) United States $0.213B 0.00
Utah Medical Products (UTMD) United States $0.205B 18.42
High Tide (HITI) Canada $0.203B 0.00
Aurora Cannabis (ACB) Canada $0.201B 59.17
OraSure Technologies (OSUR) United States $0.197B 0.00
TerrAscend (TSNDF) Canada $0.182B 0.00
Organigram Global (OGI) Canada $0.174B 0.00
Accendra Health (ACH) United States $0.173B 1.74
Vireo Growth (VREOF) United States $0.170B 0.00
Sanara MedTech (SMTI) United States $0.168B 0.00
Quipt Home Medical (QIPT) United States $0.157B 0.00
Apyx Medical (APYX) United States $0.142B 0.00
FitLife Brands (FTLF) United States $0.134B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.129B 0.00
Fonar (FONR) United States $0.115B 16.42
MacroGenics (MGNX) United States $0.108B 0.00
Jushi Holdings (JUSHF) United States $0.100B 0.00
Biote (BTMD) United States $0.097B 4.26
Exagen (XGN) United States $0.074B 0.00
ImmuCell (ICCC) United States $0.060B 25.39
Sharps Technology (STSS) United States $0.051B 0.00
Nephros (NEPH) United States $0.044B 31.54
Cytosorbents (CTSO) United States $0.040B 0.00
Rockwell Medical (RMTI) United States $0.040B 0.00
Veru (VERU) United States $0.037B 0.00
Modular Medical (MODD) United States $0.035B 0.00
United-Guardian (UG) United States $0.030B 15.35
Jin Medical (ZJYL) China $0.022B 0.00
Bonk (BNKK) United States $0.021B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
Allurion Technologies (ALUR) United States $0.014B 0.00
Flora Growth (FLGC) United States $0.009B 0.00
INLIF (INLF) China $0.007B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
Zynex (ZYXI) United States $0.004B 0.00
Functional Brands (MEHA) United States $0.003B 0.00
Meihua Medical Technologies (MHUA) China $0.002B 0.00
Agape ATP (ATPC) $0.002B 0.00
Akanda (AKAN) Canada $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00
Trinity Biotech (TRIB) Ireland $0.000B 0.00